Explore
Premium
Sign Up
Log In
CRT 2017 : Optimization of Anticoagulation for STEMI Therapy - Supported by educational grants from AstraZenca, Chiesi USA, Inc. and Medicure, Inc.
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
Optimization of Anticoagulation for STEMI Therapy - Supported by educational grants from AstraZenca, Chiesi USA, Inc. and Medicure, Inc.
Featuring
Kyle Buchanan
Paul Gurbel
Michael Lipinski
M Chadi Alraies
A. Michael Lincoff
Gary Schaer
David Cohen
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Case Presentation - Kyle Buchanan
Is There Such a Thing as Adequate P2Y12 Pretreatment for ACS?: Contemporary Use of IV Antiplatelet Agents - Paul Gurbel
Maintaining Ischemic Protection While Improving Safety Outcomes: Can We Standardize Short Infusion Glycoprotein IIb/IIIa Inhibitor Use? - Michael Lipinski
Antiplatelet Options in the Cathlab: How Can We Find Value? - Michael Lipinski
Case Presentation - M Chadi Alraies
Should We Preload STEMI Patients With Antiplatelet Therapy? - A. Michael Lincoff
Antiplatelet Therapy for STEMI: The Case for Cangrelor - Gary Schaer
The Role of Long-Term DAPT after STEMI - David Cohen
Target Audience
Learning Objectives
Related Moments
CRT 2016 Coronary - CTO Academy - Best Abstracts
Conference
CTO Academy - Best Abstracts at CRT 2016
CRT 2015 Technology & Innovation - DES Thrombosis Restenosis and DAPT Duration
Conference
A session on DES Thrombosis Restenosis and DAPT Duration from CRT 2015
Vascular Access And Chronic Total Occlusion Angioplasty
Journal
Article on Vascular Access And Chronic Total Occlusion Angioplasty
Loading Simple Education